- 2 Résultats
prix le plus bas: € 109,00, prix le plus élevé: € 173,95, prix moyen: € 141,48
1
Commander
sur Indigo.ca
(environ € 173,95)
CommanderLien sponsorisé

Cancer Pharmacogenetics - nouveau livre

ISBN: 9780387691336

The field of pharmacogenetics has expanded rapidly over the past few years since the release of the working draft of the human genome project and the continuing efforts of the internation… Plus…

Frais d'envoiLivraison non-comprise
2

Springer-Verlag New York Inc.:

Cancer Pharmacogenetics - nouveau livre

2008, ISBN: 9780387691336

The field of pharmacogenetics has expanded rapidly over the past few years since the release of the working draft of the human genome project and the continuing efforts of the internation… Plus…

  - Nieuw, Vermoedelijk 4-6 weken Frais d'envoiVermoedelijk 4-6 weken, Livraison non-comprise bol.com

1Comme certaines plateformes ne transmettent pas les conditions d'expédition et que celles-ci peuvent dépendre du pays de livraison, du prix d'achat, du poids et de la taille de l'article, d'une éventuelle adhésion de la plateforme, d'une livraison directe par la plateforme ou via un prestataire tiers (Marketplace), etc. il est possible que les frais de livraison indiqués par eurolivre ne correspondent pas à ceux de la plateforme qui propose l'article.

Données bibliographiques du meilleur livre correspondant

Détails sur le livre

The field of pharmacogenetics has expanded rapidly over the past few years since the release of the working draft of the human genome project and the continuing efforts of the international HapMap project. Cancer therapy offers an ideal scenario for the integration of pharmacogenetics into clinical practice - often there are multiple treatment options but a finite window of time to select the correct one. The ideal of testing patients for genetic markers for chemotherapy efficacy and/or toxicity is becoming a reality with FDA approved clinical tests and genotype-guided clinical trials. This volume is designed to offer an overview of the role of pharmacogenetics in cancer treatment, from the history of the field through to its integration into clinical practice. TOC:A History of Pharmacogenetics.- Pharmacokinetics and pharmacogenetics.- drug targets and pharmacogenetics.- Pharmacodynamics and pharmacogenetics.- toxicity and pharmacogentics.- Leukemia: the TPMT Example.- Solid tumors I: The UGT1A1 Example.- Solid Tumors II: the EGFR Example.- Novel Pharmacogenetic markers: whole genome association studies.- In silico resources for cancer pharmacogenetics: databases and knowledge bases.- pharmacogenetics methodology-overview of available methods.- From bedside to clinical practice I: Clinical trials.- From Bedside to Clinical Practice II: FDA.- The Future of Cancer Pharmacogenetics

Informations détaillées sur le livre - Cancer Pharmacogenetics


EAN (ISBN-13): 9780387691336
ISBN (ISBN-10): 0387691332
Date de parution: 2008
Editeur: Springer

Livre dans la base de données depuis 2008-03-03T08:33:19+01:00 (Zurich)
Page de détail modifiée en dernier sur 2017-02-01T21:28:53+01:00 (Zurich)
ISBN/EAN: 0387691332

ISBN - Autres types d'écriture:
0-387-69133-2, 978-0-387-69133-6
Autres types d'écriture et termes associés:
Titre du livre: pharmacogenetics, cancer


Données de l'éditeur

Auteur: Sharon Marsh
Titre: Cancer Pharmacogenetics
Editeur: Springer; Springer US
280 Pages
Date de parution: 2010-06-15
New York; NY; US
Langue: Anglais
112,30 € (DE)
115,45 € (AT)
150,65 CHF (CH)
Not available, publisher indicates OP

BB; Book; Hardcover, Softcover / Medizin/Nichtklinische Fächer; Onkologie; cancer therapy; genetics; chemotherapy; toxicity; cancer treatment; drug; leukemia; pharmacodynamics; research; pharmacokinetics; clinical trial; cancer; kinetics; B; Cancer Research; Biomedical and Life Sciences; Pharmacology/Toxicology; Health Promotion and Disease Prevention; Epidemiology; Medical Microbiology; Pharmakologie; Public Health und Präventivmedizin; Epidemiologie und medizinische Statistik; Mikrobiologie und Virologie; EA

A History of Pharmacogenetics.- Pharmacokinetics and pharmacogenetics.- drug targets and pharmacogenetics.- Pharmacodynamics and pharmacogenetics.- toxicity and pharmacogentics.- Leukemia: the TPMT Example.- Solid tumors I: The UGT1A1 Example.- Solid Tumors II: the EGFR Example.- Novel Pharmacogenetic markers: whole genome association studies.- In silico resources for cancer pharmacogenetics: databases and knowledge bases.- pharmacogenetics methodology-overview of available methods.- From bedside to clinical practice I: Clinical trials.- From Bedside to Clinical Practice II: FDA.- The Future of Cancer Pharmacogenetics
This volume is designed to offer an overview of the role of pharmacogenetics in cancer treatment, from the history of the field through to its integration into clinical practice.

< pour archiver...